Quick Takeaways
- Motif Pharmaceuticals Ltd. has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $442,434.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Motif Pharmaceuticals Ltd.
- Location
- Dublin, Ireland
- Summary
- The estimated value of insider holdings of Motif Pharmaceuticals Ltd. is at least $442,434 dollars as of 15 Feb 2024. Motif Pharmaceuticals Ltd. is the 10%+ Owner of Chromocell Therapeutics Corp and owns shares of Pelthos Therapeutics Inc. (PTHS) stock worth about $442.4K.
- Signature
- Motif Pharmaceuticals Ltd., By /s/ Zachary Klein
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Motif Pharmaceuticals Ltd. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Chromocell Therapeutics Corp ($442,434).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Motif Pharmaceuticals Ltd.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PTHS | Chromocell Therapeutics Corp | 10%+ Owner | $442,434 | 15 Feb 2024 |
Insider Transactions Reported by Motif Pharmaceuticals Ltd.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.